Literature DB >> 17018524

SRC tail phosphorylation is limited by structural changes in the regulatory tyrosine kinase Csk.

Scot A Lieser1, Jennifer Shaffer, Joseph A Adams.   

Abstract

Src family tyrosine kinases are down-regulated through phosphorylation of a single C-terminal tyrosine by the nonreceptor tyrosine kinase Csk. Despite the fundamental role of Csk in controlling cell growth and differentiation, it is unclear what limits this key signaling reaction and controls the production of catalytically repressed Src. To investigate this issue, stopped-flow fluorescence experiments were performed to determine which steps modulate catalysis. Both Src binding and phosphorylation can be monitored by changes in intrinsic tryptophan fluorescence. Association kinetics are biphasic with the initial phase corresponding to the bimolecular interaction of both proteins and the second phase representing a slow conformational change that coincides with the rate of maximum turnover. The kinetic transients for the phosphorylation reaction are also biphasic with the initial phase corresponding to the rapid phosphorylation and the release of phospho-Src. These data, along with equilibrium sedimentation and product inhibition experiments, suggest that steps involving Src association, phosphorylation, and product release are fast and that a structural change in Csk participates in limiting the catalytic cycle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018524     DOI: 10.1074/jbc.M607824200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Proteins at work: a combined small angle X-RAY scattering and theoretical determination of the multiple structures involved on the protein kinase functional landscape.

Authors:  Michael A Jamros; Leandro C Oliveira; Paul C Whitford; José N Onuchic; Joseph A Adams; Donald K Blumenthal; Patricia A Jennings
Journal:  J Biol Chem       Date:  2010-08-26       Impact factor: 5.157

2.  Substrate-specific reorganization of the conformational ensemble of CSK implicates novel modes of kinase function.

Authors:  Michael A Jamros; Leandro C Oliveira; Paul C Whitford; José N Onuchic; Joseph A Adams; Patricia A Jennings
Journal:  PLoS Comput Biol       Date:  2012-09-20       Impact factor: 4.475

3.  Theoretical Insights Reveal Novel Motions in Csk's SH3 Domain That Control Kinase Activation.

Authors:  Sulyman Barkho; Levi C T Pierce; Sheng Li; Joseph A Adams; Patricia A Jennings
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

4.  Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells.

Authors:  C S Pichot; S M Hartig; L Xia; C Arvanitis; D Monisvais; F Y Lee; J A Frost; S J Corey
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

5.  Distal loop flexibility of a regulatory domain modulates dynamics and activity of C-terminal SRC kinase (csk).

Authors:  Sulyman Barkho; Levi C T Pierce; Maria L McGlone; Sheng Li; Virgil L Woods; Ross C Walker; Joseph A Adams; Patricia A Jennings
Journal:  PLoS Comput Biol       Date:  2013-09-05       Impact factor: 4.475

6.  Structural basis for the recognition of c-Src by its inactivator Csk.

Authors:  Nicholas M Levinson; Markus A Seeliger; Philip A Cole; John Kuriyan
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.